About Fabtech Technologies Ltd
Fabtech Technologies operates as a biopharma engineering company. The Company offers design, engineering, procurement, installation and testing of pharmaceutical equipment. Fabtech Technologies serves pharmaceutical, healthcare, and biotech sector in India.
Founded
2018
CEO
Naushad Panjwani
Employees
186
HQ
Mumbai, India
Finished Products
1Sale of products
₹226.61Cr2Installation
₹5.60Cr3commissioning a
₹4.21CrRaw Materials
1Purchases of Stock in Trade
₹129.97CrAbout Fabtech Technologies Ltd
Fabtech Technologies operates as a biopharma engineering company. The Company offers design, engineering, procurement, installation and testing of pharmaceutical equipment. Fabtech Technologies serves pharmaceutical, healthcare, and biotech sector in India.
Founded:2018
CEO:Naushad Panjwani
Employees:186
HQ:Mumbai, India
Finished Products
1Sale of products
₹226.61Cr2Installation
₹5.60Cr3commissioning a
₹4.21CrRaw Materials
1Purchases of Stock in Trade
₹129.97CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹263
52W Low
₹133
Volume62.16K
Avg VolumeN/A
BetaN/A
Dividend Yield0.41%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
13.53x
Valuation
P/B Ratio
1.57x
Valuation
EPS
₹10.95
Valuation
Dividend Yield
0.41%
Valuation
ROE
9.14%
Profitability
ROCE
10.71%
Profitability
Revenue by Segment
Contribution & growth by business line
No segment revenue data available
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.17x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
19.0%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.